Anwuligan inhibited the growth and metastasis of NSCLC cells in vivo and in vitro by upregulating let‐7c‐3p expression through the PI3K/AKT/mTOR signaling pathway. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.